← All organizations
Highest phase reached
Phase 4
First clinical trial
Jul 16, 2019Last known activity
Nov 2, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (8 distinct, 5 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Indications
Recent trials (6)
- NCT06061536Study directorPhase 2Nov 2, 2023
- NCT05182463Overall official - principal investigatorPhase 4Jan 8, 2022
- NCT05182463OfficialPhase 4Jan 8, 2022
- NCT04939441CollaboratorPhase 4Apr 20, 2021
- NCT04543643Lead sponsorPhase 3Oct 15, 2020
- NCT04028323CollaboratorPhase 4Jul 16, 2019
Details
- Last known activity
- Nov 2, 2023